HindBio Science Stock Price Today (NSE: HINDIBIO)
Fundamental Score
HindBio Science Share Price — Live NSE/BSE Price, Fundamentals & Analysis
HindBio Science share price today is ₹5.80, up +0.00% on NSE/BSE as of 8 April 2026. HindBio Science (HINDIBIO) is a Small-cap company in the Software Products sector with a market capitalisation of ₹5.94 (Cr). The 52-week high for HINDIBIO share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 297.13x, HINDIBIO is currently trading above its industry average P/E of 36.75x. The company has a Return on Equity (ROE) of 11.76% and a debt-to-equity ratio of 3.05.
HindBio Science Share Price Chart — NSE/BSE Historical Performance
HindBio Science share price chart: 0.00% return over the past month. 52-week high ₹N/A, 52-week low ₹N/A.
AI Research Briefing
Powered by Gemini · 2026-04-08
HINDIBIO is a micro-cap value trap driven by fleeting technicals; stay far away.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Hindustan Bio Sciences' (HINDIBIO) investment rating was upgraded from Strong Sell to Sell on April 7, 2026, driven by mildly bullish technical indicators, despite weak financials. A golden cross formed on April 7, 2026, but the stock declined 4.94% the same day. The trading window for dealing in securities is closed from April 1, 2026, until 48 hours after the announcement of audited financial results for the year ending March 31, 2026.
CORE STORY (THE REAL GAME)
This is a micro-cap stock swinging on technicals, detached from fundamentals. The market's chasing short-term price action, ignoring the underlying rot.
- Mildly bullish technical indicators
- Short-term price increase
- Golden cross formation
- Unexpected order wins
- Significant improvement in quarterly results
- Major acquisition
- Micro/SME cap: liquidity risk
- Negative sales CAGR
- High debt/equity ratio
No institutional interest (FII: 0.0%, DII: 0.0%). Promoter holding stagnant at 12.19%.
The Indian software market is projected to grow, but HINDIBIO's fundamentals suggest it won't benefit.
No: Free Cash Flow 5Y: ₹-1.02 Cr
Expect continued volatility and potential downside due to weak fundamentals. Any positive movement is likely a dead cat bounce.
Primary Thesis Risk
Fundamental weaknesses will eventually overwhelm any short-term technical gains.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
HindBio Science Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
HindBio Science Fundamental Analysis & Valuation Benchmarking
Educational evaluation of HINDIBIO across key market metrics for learning purposes.
Positive Indicators
1 factors identified
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
12 factors identified
Suboptimal ROCE (2.95%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-31.13%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Premium Valuation Risk (P/E: 297.13x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-175.00%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-100.00%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-16.03% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Earnings Growth (4.56% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (4.56% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Elevated Debt Levels (D/E: 3.05)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Negative Free Cash Flow (₹-1.02 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Low Promoter Commitment (12.19%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
HindBio Science vs Software Products Peers
Peer Comparison - Software Products
Compare HindBio Science with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
HindBio ScienceHindBio Science...Selected✓ HINDIBIO • 532041 | 0/100 | ₹5.80₹6 | ₹5.94₹5.94 | 297.13Average 297.1 Average | 11.76%Average 11.76% Average | 2.95%Poor 2.95% Poor | 3.05Poor 3.0 Poor | 4.56%Average 4.56% Average | -16.03%Poor -16.03% Poor | 0.00% |
55.8/100 | ₹10191.00₹10191 | ₹70893.63₹70893.63 | 29.87Average 29.9 Average | 29.34%Excellent 29.34% Excellent | 40.60%Excellent 40.60% Excellent | 0.00Excellent 0.0 Excellent | 10.23%Good 10.23% Good | 7.09%Good 7.09% Good | 3.25% | |
Ce Info Systems LtdCe Info Systems... MAPMYINDIA • 543425 | 61.7/100 | ₹840.50₹841 | ₹9148.67₹9148.67 | 62.82Average 62.8 Average | 17.62%Good 17.62% Good | 24.13%Excellent 24.13% Excellent | 0.01Excellent 0.0 Excellent | 44.27%Excellent 44.27% Excellent | 25.53%Excellent 25.53% Excellent | 0.21% |
Tanla Platforms LtdTanla Platforms... TANLA • 532790 | 69.1/100 | ₹517.45₹517 | ₹7392.75₹7392.75 | 15.42Average 15.4 Average | 24.10%Excellent 24.10% Excellent | 29.19%Excellent 29.19% Excellent | 0.03Excellent 0.0 Excellent | 38.24%Excellent 38.24% Excellent | 15.70%Excellent 15.70% Excellent | 2.15% |
Nucleus Software Exports LtdNucleus Softwar... NUCLEUS • 531209 | 56.5/100 | ₹726.25₹726 | ₹2429.96₹2429.96 | 15.07Average 15.1 Average | 16.82%Good 16.82% Good | 22.60%Excellent 22.60% Excellent | 0.01Excellent 0.0 Excellent | 9.56%Good 9.56% Good | 9.83%Good 9.83% Good | 1.35% |
Ramco Systems LtdRamco Systems L... RAMCOSYS • 532370 | 34/100 | ₹447.05₹447 | ₹2096.06₹2096.06 | 241.76Average 241.8 Average | -10.87%Poor -10.87% Poor | -5.40%Poor -5.40% Poor | 0.15Excellent 0.1 Excellent | — — | 0.78%Average 0.78% Average | 0.00% |
Lucent Industries LtdLucent Industri... LUCENT • 539682 | 29.6/100 | ₹1180.55₹1181 | ₹1731.07₹1731.07 | 232.05Average 232.1 Average | — — | — — | 0.65Good 0.7 Good | — — | — — | 0.04% |
Quick Heal Technologies LtdQuick Heal Tech... QUICKHEAL • 539678 | 32/100 | ₹174.62₹175 | ₹1668.27₹1668.27 | — — | 0.63%Poor 0.63% Poor | -0.24%Poor -0.24% Poor | 0.00Excellent 0.0 Excellent | -47.96%Poor -47.96% Poor | -0.47%Poor -0.47% Poor | 0.00% |
Unicommerce eSolutions LtdUnicommerce eSo... UNIECOM • 544227 | 35.1/100 | ₹85.49₹85 | ₹1431.00₹1431.00 | 73.92Average 73.9 Average | 24.78%Excellent 24.78% Excellent | 31.37%Excellent 31.37% Excellent | 0.06Excellent 0.1 Excellent | — — | — — | 0.00% |
Blue Cloud Softech Solutions LtdBlue Cloud Soft... BLUECLOUDS • 539607 | 32.4/100 | ₹18.00₹18 | ₹886.96₹886.96 | 16.98Average 17.0 Average | 44.47%Excellent 44.47% Excellent | 37.07%Excellent 37.07% Excellent | 0.55Good 0.6 Good | — — | — — | 0.00% |
Subex LtdSubex Ltd... SUBEXLTD • 532348 | 14.2/100 | ₹10.19₹10 | ₹674.17₹674.17 | — — | -11.26%Poor -11.26% Poor | -6.44%Poor -6.44% Poor | 0.09Excellent 0.1 Excellent | — — | -4.79%Poor -4.79% Poor | 0.00% |
Top Software Products Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Oracle Financial Services Software Limited share price70893.63 Cr
- Ce Info Systems Ltd share price9148.67 Cr
- Tanla Platforms Ltd share price7392.75 Cr
- Nucleus Software Exports Ltd share price2429.96 Cr
- Ramco Systems Ltd share price2096.06 Cr
HindBio Science Quarterly Performance
Latest quarterly metrics for HINDIBIO — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-100.00%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-175.00%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
-16.03%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
4.56%
Compounded annual net profit growth over 5 years
HindBio Science Financial Statements
Annual income statement, balance sheet and cash flow for HindBio Science (HINDIBIO) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for HindBio Science
About HINDIBIO (HindBio Science)
HindBio Science (HINDIBIO) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Software Products sector with a curr...ent market capitalisation of ₹5.94 (Cr). HindBio Science has delivered a Return on Equity (ROE) of 11.76% and a ROCE of 2.95%. The debt-to-equity ratio stands at 3.05, reflecting the company's capital structure. Investors tracking HINDIBIO share price can monitor key metrics including P/E ratio, promoter holding of 12.19%, and quarterly earnings growth.
Company Details
HINDIBIO Share Price: Frequently Asked Questions
What is the current share price of HindBio Science?
HindBio Science (HINDIBIO) trades at ₹5.80 on NSE and BSE. Market cap ₹5.94 (Cr). Educational data only.
What is the P/E ratio of HindBio Science?
HindBio Science has a P/E of 297.13x vs industry average 36.75x.
What is the Bull Run score for HindBio Science?
HindBio Science has a Bull Run score of 0/100 based on 25+ financial parameters.
Does HindBio Science pay dividends?
HindBio Science has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of HindBio Science?
HindBio Science has ROE of 11.76%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of HindBio Science?
HindBio Science has debt-to-equity of 3.05.
Is HindBio Science a good investment?
Bull Run gives HindBio Science a score of 0/100. This is not investment advice — consult a SEBI-registered advisor.